New enzyme could assist in treatment of Type 2 diabetes

Researchers have discovered an enzyme which, when suppressed, promotes insulin secretion and reduces hyperglycaemia associated with Type 2 diabetes.

The enzyme, named Alpha/beta hydrolase domain-6, breaks down a signal molecule named monoacylglycerol, which is instrumental in promoting insulin secretion in the blood.

Study co-director Mark Prentki said the identification of both ABHD6 and the signal was necessary to developing better therapeutics against Type 2 diabetes.

Read more at University of Montreal

Expert Database

Want to write?

Write an article and join a growing community of more than 54,400 academics and researchers from 2,115 institutions.

Register now